Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Using eye imaging to study blood vessel changes in patients with high blood pressure and kidney disease

Official title: Assessment of Retinal Vasculature Using Optical Coherence Tomography in Health, Hypertension & Chronic Kidney Disease.

Run by University of Edinburgh · NCT02132741 · Data updated 2026-11-12

This study is testing if eye imaging can help show changes in blood vessels for people with high blood pressure and kidney disease compared to healthy individuals.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity of Edinburgh
Academic / other
Locations1 site (Edinburgh, Midlothian)
StatusRecruiting
StartedMay 16, 2014
Main results expectedDecember 31, 2027
Study endsSeptember 2028
Registry record updatedMay 13, 2026
Trial IDNCT02132741 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-80 with hypertension and/or chronic kidney disease.

Probably not a fit

Patients with significant eye disease or those who have had recent eye surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between hypertension, chronic kidney disease (CKD), and changes in the eye's blood vessels using optical coherence tomography (OCT). By comparing images of the retinal and choroidal structures in patients with hypertension and CKD to those of healthy individuals, the study seeks to determine if OCT can effectively detect vascular changes. The non-invasive nature of OCT allows for quick and easy image acquisition, facilitating recruitment at the Royal Infirmary of Edinburgh. The findings may provide insights into how treating hypertension and CKD could improve vascular health.

Why it matters

Potential benefit: If successful, this study could enhance understanding of vascular health in patients with hypertension and CKD, potentially leading to improved treatment strategies.

How similar studies have gone: While the use of OCT in this context is relatively novel, similar studies have shown promise in detecting vascular changes in other populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female
* Age 18-80
* Body mass index ≤35
* For those with hypertension: BP ≥140/90 or on treatment for hypertension
* For those with CKD: CKD as defined by the Kidney Diseases Quality Initiative guidelines

Exclusion Criteria:

* Subject is below the age of legal consent, or is mentally or legally incapacitated
* The subject has donated blood (450 ml) within the last 4 weeks
* Past or present drug or alcohol abuse including intravenous drug abuse at any time
* Participation in another clinical trial within 1 month
* Considered to be at high risk of HIV or hepatitis B
* Patients with known eye disease, or previous eye surgery, or refractive error greater than +/- 6 dioptres.

Where it's running

  • University of Edinburgh
    Edinburgh, Midlothian, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Neeraj Dhaun, MD PhD — University of Edinburgh
  • Study coordinator: Neeraj Dhaun, MD PhD
  • Email: bean.dhaun@ed.ac.uk
  • Phone: 01312429215

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.